Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal origin

No abstract is available for this paper.

• Publication year

  2017

• Venue

  British Journal of Surgery

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/bjs.10422PMID 28112791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2016cited by this paper
• Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.

  2016cited by this paper
• Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study

  2016cited by this paper
• Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC

  2016cited by this paper
• Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2016cited by this paper
• A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC

  2015cited by this paper
• Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer

  2015cited by this paper
• A Simple Tumor Load-Based Nomogram for Surgery in Patients with Colorectal Liver and Peritoneal Metastases

  2014cited by this paper
• HIPEC + EPIC versus HIPEC‐alone: Differences in major complications following cytoreduction surgery for peritoneal malignancy

  2013cited by this paper
• Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer

  2012cited by this paper
• Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model

  2010cited by this paper
• Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

  2003cited by this paper

• Peritoneal Cancer Index Dominates Prognosis After CRS–HIPEC for Colorectal Peritoneal Metastases: A Consecutive Single-Centre Cohort with 3-Year Follow-Up

  2025cites this paper
• Can Peritoneal Cancer Index be Determined in 18F-FDG PET/CT Before Surgery in Ovarian Peritoneal Carcinomatosis?

  2025cites this paper
• MRI-guided stereotactic radiotherapy for oligometastatic peritoneal carcinomatosis: toward integrative oncologic approaches

  2025cites this paper
• Peritoneal Carcinosis: What the Radiologist Needs to Know

  2023cites this paper
• γδ T cells: Major advances in basic and clinical research in tumor immunotherapy

  2023cites this paper
• Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer

  2020cites this paper
• Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis

  2020cites this paper
• Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites

  2020cites this paper
• Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Colorectal Peritoneal Carcinomatosis

  2020cites this paper
• Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

  2019cites this paper
• Therapy and Prophylaxis of Peritoneal Metastases from Colorectal Cancer.

  2019influential citation
• Delta peritoneal cancer index (ΔPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastases.

  2019cites this paper
• Diffusion‐weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery

  2018cites this paper
• Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options

  2018cites this paper
• Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives.

  2017cites this paper
• Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives

  2017cites this paper